107 filings
EFFECT
LENZ
LENZ Therapeutics Inc.
11 Apr 24
Notice of effectiveness
12:15am
424B3
LENZ
LENZ Therapeutics Inc.
10 Apr 24
Prospectus supplement
7:37pm
S-1/A
LENZ
LENZ Therapeutics Inc.
IPO registration (amended)
8 Apr 24
6:36pm
8-K
LENZ
LENZ Therapeutics Inc.
3 Apr 24
LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials
7:32am
S-1
LENZ
LENZ Therapeutics Inc.
IPO registration
29 Mar 24
4:46pm
8-K
dawxs0 4f3po0zw
21 Mar 24
Report of Independent Registered Public Accounting Firm
8:22pm
8-K
g0qaa9b6g 6zh7
19 Mar 24
Regulation FD Disclosure
4:31pm
8-K
ep67c38k8q7
14 Mar 24
Submission of Matters to a Vote of Security Holders
4:37pm
425
hmeifnqfcn6ejxz
8 Mar 24
Business combination disclosure
5:17pm
8-K
cn9 6arukdpyo5ox
8 Mar 24
Graphite Bio Declares Special Dividend
5:13pm
425
tcg93q5un7d ytytlyp
5 Mar 24
Business combination disclosure
6:09am
8-K
k45f8fd
5 Mar 24
Other Events
6:08am
EFFECT
zx0gaknlovzla
14 Feb 24
Notice of effectiveness
12:15am
424B3
wkegwo0hbs25vlc
13 Feb 24
Prospectus supplement
4:44pm
SEC STAFF
mexq xmnceuqkc668f8
13 Feb 24
SEC staff action: Order
12:00am
CORRESP
f31yub5u3
9 Feb 24
Correspondence with SEC
12:00am
CORRESP
csqai
9 Feb 24
Correspondence with SEC
12:00am
UPLOAD
hfykkg0cy8b3qc77iry8
9 Feb 24
Letter from SEC
12:00am